Digestery
Longevity supplements › Metformin and Aging › Studies

Population study: followed a group

Study of 373 adults found no clear link between metformin gut bacteria and memory

Rosell-Díaz and colleagues · Metabolism: clinical and experimental · 2024

Original title: Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

No difference

Metformin use went with more A. muciniphila and less R. ilealis gut bacteria. Across all metformin users, this bacteria ratio was not linked to thinking test scores. In men only, it was linked to higher memory scores.

The study at a glance

Type of study
Population study: followed a group
Who or what was studied
373 people · Adults with no medical history (172), people with long-term type 2 diabetes on metformin (134) or other pills (45), and newly diagnosed people on metformin (22)
What was tested
Gut bacteria and blood chemicals in metformin users vs others, linked to memory test scores
What it measured
Several kinds of outcomes
Who has a stake
Company stake
One author gets research support from Biogaia AB and owns shares in Implexion Pharma AB and Roxbiosens Inc.
Journal
Metabolism: clinical and experimental, 2024
Source
PubMed record 38871078. This page is based on the abstract only.

How much this study counts

  • –Shows a link, not a cause: people chose their own habits, and other differences between them may explain the result.
  • ✓Followed people over time, so habits were recorded before the outcome happened.
  • •373 people.
  • •Measured several kinds of outcomes.
  • –Company stake: One author gets research support from Biogaia AB and owns shares in Implexion Pharma AB and Roxbiosens Inc.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

Each dot is one on-topic paper on this question. Steps near the top answer the question more directly.

↑ Stronger evidence

  1. Trials in people: aging and age-related disease

    1

    1 benefit

  2. Trials in people: other measures

    3

    2 no difference, 1 harm

  3. Trials in people: lab tests or safety

    6

    2 benefit, 2 mixed, 2 no difference

  4. Population studies

    8

    6 benefit, 2 no difference

    ↑ This study is the ringed dot

  5. Blood levels and genes

    0

    None among the papers we read.

  6. Animals

    3

    2 benefit, 1 harm

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does metformin slow aging in people without diabetes?”

Not shown in people without diabetes.

Confidence: low. Based on 26 on-topic papers.

Read the full answer

Of the other 7 papers on the same step: 6 benefit, 1 no difference. This one found no difference. It differs from most of them.

Other papers on the same step

See all 26 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The reviewer corrected 2 fields after reading the abstract. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.